Abiopharma

Community Health Systems to Participate in 2025 RBC Capital Markets Global Healthcare Conference

New Form SCHEDULE 13G/A - CRISPR Therapeutics AG Filed: 2025-05-14 AccNo: 0001104659-25-048312 Size: 13 KB

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2025-05-14 AccNo: 0001104659-25-048311 Size: 13 KB

New Form 144 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-05-14 AccNo: 0001959173-25-003166 Size: 6 KB

New Form SCHEDULE 13G - SOLENO THERAPEUTICS INC Filed: 2025-05-14 AccNo: 0000080255-25-000364 Size: 7 KB

New Form SCHEDULE 13G - Viatris Inc Filed: 2025-05-14 AccNo: 0000080255-25-000374 Size: 7 KB

New Form SCHEDULE 13G/A - CARGO Therapeutics, Inc. Filed: 2025-05-14 AccNo: 0000080255-25-000379 Size: 7 KB

New Form SCHEDULE 13G/A - Natera, Inc. Filed: 2025-05-14 AccNo: 0000080255-25-000358 Size: 7 KB

New Form SCHEDULE 13G/A for Quantum-Si Incorporated

New Form SCHEDULE 13G - VERACYTE, INC. Filed: 2025-05-14 AccNo: 0001104659-25-048308 Size: 13 KB

New Form SCHEDULE 13G/A - Quantum-Si Inc Filed: 2025-05-14 AccNo: 0001104659-25-048307 Size: 13 KB

New Form SCHEDULE 13G/A - CARGO Therapeutics, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000118 Size: 9 KB

New Form SCHEDULE 13G/A - Immunome Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000117 Size: 9 KB

New Form SCHEDULE 13G/A - Personalis, Inc. Filed: 2025-05-14 AccNo: 0001104659-25-048303 Size: 14 KB

New Form SCHEDULE 13G/A - Zai Lab Ltd Filed: 2025-05-14 AccNo: 0001274173-25-000116 Size: 9 KB